4.5148
Tvardi Therapeutics Inc Borsa (TVRD) Ultime notizie
Tvardi Therapeutics to Participate in the Jefferies Global Healthcare Conference in London - MarketScreener
Is Tvardi Therapeutics Inc. stock ready for a breakoutWeekly Trend Summary & AI Based Trade Execution Alerts - newser.com
Is Tvardi Therapeutics Inc. (69C) stock a safe buy pre earnings2025 Technical Patterns & High Yield Stock Recommendations - newser.com
How to track smart money flows in Tvardi Therapeutics Inc.July 2025 Momentum & Accurate Entry and Exit Point Alerts - newser.com
Technical signs of recovery in Tvardi Therapeutics Inc.2025 Major Catalysts & Technical Entry and Exit Tips - newser.com
Tvardi Therapeutics (TVRD) Competitors and Alternatives 2025 - MarketBeat
Shareholders Alert: Investigation Into Tvardi Therapeutics, Inc. (TVRD)Contact Levi & Korsinsky to Protect Your Rights - ACCESS Newswire
Tvardi Therapeutics, Inc. (TVRD) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics - The Malaysian Reserve
Why Tvardi Therapeutics Inc. (69C) stock could outperform next yearWeekly Volume Report & High Yield Equity Trading Tips - newser.com
Measuring Tvardi Therapeutics Inc.’s beta against major indicesWeekly Investment Report & Weekly Watchlist of Top Performers - newser.com
Understanding Tvardi Therapeutics Inc.’s price movementIPO Watch & Reliable Entry Point Alerts - newser.com
Does Tvardi Therapeutics Inc. stock trade at a discount to peersChart Signals & Reliable Price Action Trade Plans - newser.com
Can Tvardi Therapeutics Inc. (69C) stock hold up in economic slowdownMarket Performance Report & Daily Price Action Insights - newser.com
Will Tvardi Therapeutics Inc. stock benefit from green energy trendsWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
What data driven models say about Tvardi Therapeutics Inc.’s futureJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
Heatmap analysis for Tvardi Therapeutics Inc. and competitors2025 Big Picture & Real-Time Volume Surge Alerts - newser.com
How to interpret RSI for Tvardi Therapeutics Inc. stockTake Profit & Weekly Breakout Stock Alerts - newser.com
Can Tvardi Therapeutics Inc. stock deliver consistent earnings growthJuly 2025 Movers & AI Based Buy and Sell Signals - newser.com
Using Bollinger Bands to evaluate Tvardi Therapeutics Inc.July 2025 Intraday Action & Free Fast Gain Swing Trade Alerts - newser.com
Key resistance and support levels for Tvardi Therapeutics Inc.Portfolio Growth Summary & High Accuracy Buy Signal Tips - newser.com
What to do if you’re stuck in Tvardi Therapeutics Inc.July 2025 Pullbacks & Safe Capital Growth Stock Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tvardi Therapeutics, Inc. (TVRD) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
2025-11-02 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tvardi Therapeutics, Inc. (TVRD) and Encourages Investors to Learn More About the Investigation | NDAQ:TVRD | Press Release - Stockhouse
Tvardi Therapeutics, Inc. (TVRD) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Why Tvardi Therapeutics Inc. stock is recommended by analystsJuly 2025 Highlights & Free Low Drawdown Momentum Trade Ideas - newser.com
How Tvardi Therapeutics Inc. stock reacts to global recession fears2025 Support & Resistance & Verified Swing Trading Watchlists - newser.com
Will Tvardi Therapeutics Inc. benefit from macro trendsJuly 2025 Review & Capital Protection Trading Alerts - newser.com
TVRD Investors Have Opportunity to Join Tvardi Therapeutics, Inc. Fraud Investigation with the Schall Law Firm - The AI Journal
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tvardi Therapeutics, Inc. (TVRD) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
2025-10-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Tvardi Therapeutics, Inc. (TVRD) and Encourages Stockholders to Learn More About the Investigation | NDAQ:TVRD | Press Release - Stockhouse
Using AI based signals to follow Tvardi Therapeutics Inc.2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):